From October 1, 2021 to December 31, 2021, the company has repurchased 1,771,500 shares, representing 0.12% for CNY 24.24 million. With this, the company has completed the repurchase of 3,330,700 shares, representing 0.22% for CNY 45.21 million under the buyback announced on June 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.93 CNY | +1.68% | -2.93% | -18.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.16% | 2.87B | |
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B | |
+40.06% | 1.45B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on June 26, 2021.